These genes are highly penetrant; there is a reported cumulative risk of almost 80% for female breast cancers in BRCA1 mutations, as well as a 50% risk for BRCA2 mutation carriers [[3], [4], [5]]. Here, BRCA1 is linked to breast carcinoma.